Access to premium content is restricted to healthcare professionals / registered members. Login with your email address to continue.
Forgot Your Password?
Follow Topic
Bookmark
Copy Link
The National Pharmacy Association said regulations and guidance must "keep pace” with the huge demand for weight loss medicines.
05 Jun 2025 , 1 Min Article
Guselkumab already approved for plaque psoriasis and psoriatic arthritis, but studies show it is also effective in moderate to severe Crohn’s disease and UC.
20 May 2025 , 1 Min Article
Twelve suspects arrested after dawn raids across the West Midlands and the Northwest of England in MHRA's largest investigation into organised medicines trafficking to date.
29 Apr 2025 , 1 Min Article
Coroner reports on benzodiazepine death of vulnerable 45-year-old man in Wales
28 Apr 2025 , 1 Min Article
Following a review the MHRA has published an opinion on the regulatory status of products containing cannabidiol (CBD).
15 Apr 2025 , 1 Min Article
Lawrence Tallon takes over from June Raine at MHRA; Dr Penny Dash is new chair of NHS England.
04 Mar 2025 , 1 Min Article
Nemolizumab (Nemluvio, Galderma) has been approved by the MHRA for the treatment of two skins conditions.
18 Feb 2025 , 1 Min Article
The MHRA has launched a consultation on regulatory guidance for individualised mRNA cancer immunotherapies (cancer vaccines).
04 Feb 2025 , 1 Min Article
Over £40m worth of illegal medicines taken out of black market circulation in 2024.
29 Jan 2025 , 2 Min Article
MHRA interim executive director James Pound said: "We proactively take action as information and intelligence is shared with us.”
24 Jan 2025 , 1 Min Article
Leeds manufacturer has been selling lidocaine spray without authorisation
14 Nov 2024 , 1 Min Article
MHRA issues GLP-1 receptor agonist warning to pharmacy teams.
24 Oct 2024 , 2 Min Article
New regulations mean that products with a very short shelf life, and personalised medicines such as gene therapy, can more easily be made in or near a hospital setting
22 Oct 2024 , 2 Min Article
The MHRA approved two “presentations of the adapted vaccine” after they met its standards of safety, quality, and effectiveness.
11 Oct 2024 , 1 Min Article
Elafibranor (Iqirvo) has been approved by the MHRA to treat adult patients with a rare type of liver disease known as primary biliary cholangitis
08 Oct 2024 , 1 Min Article
Fruquintinib stops tumours making new blood vessels, which normally provide the tumour with nutrients and oxygen.
20 Sep 2024 , 1 Min Article
